|
| Monday, 28 November 2011, 10:00 HKT/SGT | |
| |  | |
Source: A*STAR | |
|
|
|
SINGAPORE, Nov 28, 2011 - (ACN Newswire) - The Institute of Microelectronics (IME), a research institute of the Agency for Science, Technology and Research (A*STAR), has announced plans to commercialize key innovations in silicon chips designed to support high speed, high bandwidth optical communications. These chips were developed as part of IME's Silicon Photonics research platform.
Further enhancements to the chips were enabled, through strategic collaboration with Alcatel-Lucent Bell Laboratories - one of the world's leading optical communications innovators.
Working with a global semiconductor foundry, GLOBALFOUNDRIES, IME and Alcatel-Lucent plan to bring innovative silicon component designs from research to commercial fabrication readiness within the next few years.
These scalable and cost-effective silicon building blocks will be made accessible to photonics developers to create new products and propagate the benefits of dramatically increased data rate and processing power, at a reduced cost to the industry.
The collaboration leverages Bell Labs' extensive design experience and leading-edge research capability with the development expertise of IME to create a library of silicon photonics devices with the requisite process control monitors (PCMs) and process design kits (PDKs). These photonic devices, ranging from next-generation high-speed optical modulators, germanium photo-detectors, waveguides and other common photonic circuits found in networking equipment will be offered as a result of this collaboration.
"This milestone reflects the rapidly growing commercial significance of silicon photonics," cited Prof. Dim-Lee Kwong, the Executive Director of IME. "IME will continue to enhance our Silicon Photonics technology platform and work with our strategic partners to bring the benefits of silicon photonics to the industry worldwide."
"I'm delighted that IME and GLOBALFOUNDRIES are working with Bell Labs to accelerate the development of the exciting silicon photonics technology, which holds such promise for use in communication systems," said, Alice White, Chief Scientist, Alcatel-Lucent Bell Labs. "Bell Labs has been actively engaging leading microelectronics research institutes in silicon photonics research - it is exciting to see these efforts moving forward into the commercial realm."
"GLOBALFOUNDRIES is excited to partner with IME to deliver photonics solutions to customers such as Alcatel-Lucent. Through innovative design kits and advanced materials fabrication techniques, the GLOBALFOUNDRIES - IME team intends to expand the photonics design and manufacturing portfolio to our existing and future customers who are looking for reliable high-volume manufacturing service," said Raj Kumar, Senior Vice President for GLOBALFOUNDRIES' 200mm Business Unit and General Manager for Singapore.
About IME's Nano-Photonics Programme
IME's Nano-Photonics Programme focuses on silicon photonics, an area of research which has attracted substantial industry interest. Silicon photonics enables manufacturers to integrate optical functions in silicon wafers, just as electronic devices are today, thus enabling them to take advantage of the infrastructure and R&D know-how of silicon manufacturing accrued over the past 40 years. The result is a 10 to 100 times reduction in cost, surmounting the main obstacle that has hindered the widespread adoption of photonics.
By leveraging the advanced silicon micro- and nano-fabrication technologies in IME, researchers under the programme have made significant progress in developing CMOS platform-based silicon photonic devices with applications in high-speed optical interconnects and light-emitters. Their achievements include having demonstrated low loss light coupling, transmission and wavelength-division-multiplexing as well as fast electro-optical modulation, photo-detection and light emission in silicon - which are the important building blocks towards realising high performance photonic integrated circuits in silicon.
About Institute of Microelectronics (IME)
The Institute of Microelectronics (IME) is a research institute of the Science and Engineering Research Council of the Agency for Science, Technology and Research (A*STAR). Positioned to bridge the R&D between academia and industry, IME's mission is to add value to Singapore's semiconductor industry by developing strategic competencies, innovative technologies and intellectual property; enabling enterprises to be technologically competitive; and cultivating a technology talent pool to inject new knowledge to the industry. Its key research areas are in integrated circuit design, advanced packaging, bioelectronics and medical devices, MEMS, nano-electronics, and photonics. For more information, visit IME at www.ime.a-star.edu.sg.
About Agency for Science, Technology and Research (A*STAR)
The Agency for Science, Technology and Research (A*STAR) is the lead agency for fostering world-class scientific research and talent for a vibrant knowledge-based and innovation-driven Singapore. A*STAR oversees 14 biomedical sciences and physical sciences and engineering research institutes, and six consortia & centres, located in Biopolis and Fusionopolis as well as their immediate vicinity. A*STAR supports Singapore's key economic clusters by providing intellectual, human and industrial capital to its partners in industry. It also supports extramural research in the universities, and with other local and international partners. For more information about A*STAR, please visit www.a-star.edu.sg.
About GLOBALFOUNDRIES
GLOBALFOUNDRIES is the world's first full-service semiconductor foundry with a truly global manufacturing and technology footprint. Launched in March 2009 through a partnership between AMD [NYSE: AMD] and the Advanced Technology Investment Company (ATIC), GLOBALFOUNDRIES provides a unique combination of advanced technology, manufacturing excellence and global operations. With the integration of Chartered Semiconductor in January 2010, GLOBALFOUNDRIES significantly expanded its capacity and ability to provide best-in-class foundry services from mainstream to the leading edge. GLOBALFOUNDRIES is headquartered in Silicon Valley with manufacturing operations in Singapore, Germany, and a new leading-edge fab under construction in Saratoga County, New York. These sites are supported by a global network of R&D, design enablement, and customer support in Singapore, China, Taiwan, Japan, the United States, Germany, and the United Kingdom. For more information on GLOBALFOUNDRIES, visit http://www.globalfoundries.com.
About Alcatel-Lucent (Euronext Paris and NYSE: ALU)
The long-trusted partner of service providers, enterprises, strategic industries and governments around the world, Alcatel-Lucent is a leader in mobile, fixed, IP and Optics technologies, and a pioneer in applications and services. Alcatel-Lucent includes Bell Labs, one of the world's foremost centres of research and innovation in communications technology. With operations in more than 130 countries and one of the most experienced global services organizations in the industry, Alcatel-Lucent is a local partner with global reach. The Company achieved revenues of Euro 16 billion in 2010 and is incorporated in France and headquartered in Paris. For more information, visit Alcatel-Lucent on: http://www.alcatel-lucent.com, read the latest posts on the Alcatel-Lucent blog http://www.alcatel-lucent.com/blog and follow the Company on Twitter: http://twitter.com/Alcatel_Lucent.
Contact:
GLOBALFOUNDRIES
Gina Wong
DID: +65-6670-1808
Asia Pacific and Japan
ginawong@globalfoundries.com
Alcatel-Lucent
Wendy Zajack
DID: +33-703-943-6298
wendy.zajack@alcatel-lucent.com
IME
Cindy Chew
DID: +65-6770-5375
Email: chewwfc@ime.a-star.edu.sg
Topic: New Service
Source: A*STAR
Sectors: Electronics
http://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
|
| A*STAR |
| Dec 6, 2022 14:00 HKT/SGT |
|
Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing |
| June 2, 2022 21:00 HKT/SGT |
|
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies |
| June 2, 2022 21:00 HKT/SGT |
|
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies |
| Sept 30, 2021 16:00 HKT/SGT |
|
A*STAR and Local SME Work with Vaccination Centres to Deploy AVID System for Filling Syringes |
| July 31, 2020 08:00 HKT/SGT |
|
Singapore Cancer Drug ETC-159 Advances Further in Clinical Trials |
| July 24, 2020 17:00 HKT/SGT |
|
MP Biomedicals and A*STAR Co-Develop Rapid Antibody Test Kit for SARS-CoV-2 |
| Oct 22, 2019 04:00 HKT/SGT |
|
Fujitsu, SMU and A*STAR Launch Digital Platform Experimentation Project using Quantum-Inspired Computing and Deep Learning Technology |
| June 28, 2019 08:00 HKT/SGT |
|
Singapore's Drug Development Efforts Given Additional Momentum with National Platforms |
| Apr 5, 2019 18:00 HKT/SGT |
|
Passing of Dr Sydney Brenner, Nobel Laureate, Renowned Pioneer in Molecular Biology, A*Star Senior Fellow |
| Jan 21, 2019 13:00 HKT/SGT |
|
Branched-Chain Amino Acids Found to Regulate the Development and Progression of Cancer |
| More news >> |
 |
|
|
|
